Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist [8]

Fertility and Sterility

Volumn 79, Issue 3, 2003, Pages 648-650

  Schröder, Annika K ^a   Schöpper, Beate ^a   Al Hasani, Safaa ^a   Löning, Martin ^a   Diedrich, Klaus ^a   Ludwig, Michael ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b University Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; DECAPEPTYL GYN DEPOT; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LIQUID NITROGEN; MAGNESIUM CHLORIDE; POVIDONE; RECOMBINANT FOLLITROPIN; SODIUM CHLORIDE; TRIPTORELIN;

ASSAY; CELL FUNCTION; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; LETTER; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OOCYTE; PRIORITY JOURNAL; RANK SUM TEST; SPERM; STATISTICAL SIGNIFICANCE; STIMULATION; THICKNESS; WORLD HEALTH ORGANIZATION; ZONA PELLUCIDA;

EID: 0037336873     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04808-2     Document Type: Letter

References (22)

1. Ortmann O., Oltmanns K., Weiss J.M. Effect of GnRh antagonist cetrorelix on steroidogenesis in human granulosa lutein cells. Hum Reprod. 13:1998;P252.
2. Lin Y., Kahn J.A., Hillensjo T. Is there a difference in the function of granulosa-cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Hum Reprod. 14:1999;885-888.
3. Minaretzis D., Alter M.M., Oskowitz S.P. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa lutein cells . Am J Obstet Gynecol. 172:1995;1518-1525.
4. Morales P., Kerr B., Oliva C., Pizarro C., Kong M. Gonadotrophin-releasing hormone antagonists inhibit sperm binding to the human zona pellucida. Hum Reprod. 14:1999;2069-2074.
5. Morales P., Pizarro C., Kong M., Kerr B., Ceric F., Vigil P. Gonadotropin-releasing hormone-stimulated sperm binding to the human zona is mediated by a calcium influx. Biol Reprod. 63:2000;635-642.
6. World Health Organization, 4th ed. Berlin: Springer: 1999.
7. Schöpper B., Ludwig M., Edenfeld J., Al-Hasani S., Diedrich K. Possible applications of lasers in assisted reproductive technologies. Hum Reprod. 14:(Suppl 1):1999;186-193.
8. Edenfeld J., Schöpper B., Sturm R., Diedrich K., Al-Hasani S. Application of a 1.48 μ, diode laser for dissecting oocytes into two identical hemizonae for the hemizona assay. Int J Andrology. 24:2001;1-6.
9. Hernandez E. Embryo implantation and GnRH antagonists, embryo implantation the Rubicon for GnRh antagonists . Hum Reprod. 15:2000;1211-1216.
10. Ortmann O., Weiss J.M., Diedrich K. Embryo implantation and GnRH antagonists ovarian actions of GnRH antagonists . Hum Reprod. 16:2001;608-611.
11. Latouche J., Crumeyrolle-Arias M., Jordan D. GnRH receptors in human granulosa cells anatomical localization and characterization by autoradiographic studies . Endocrinology. 125:1989;1739-1741.
12. Bramley T.A., Menzies G.S., Baird T.D. Specific binding of gonadotropin-releasing hormone and an agonist in human corpus luteum homogenates characterization, properties and luteal phase levels . J Clin Endocrinol Metab. 61:1985;834-841.
13. Clayton C.E., Huhtaniemi I.T. Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature. 299:1982;56-59.
14. Bertrand E., Van den Bergh M., Englert Y. Does zona pellucida thickness influence the fertilization rate? Hum Reprod. 10:1995;1189-1193.
15. Cohen J., Alikani M., Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis. Hum Reprod. 7:1992;685-691.
16. Wright G., Wiker S., Elsner C., Kort H., Massey J., Cohen J., et al. Observations on the morphology of human zygotes, pronuclei and nucleoli and implications for cryopreservation. Hum Reprod. 5:1990;109-115.
17. Cohen J., Inge K.L., Suzman K., Wiker S., Wright G. Videocinematography of fresh and cryopreserved embryos a retrospective analysis of embryonic morphology and implantation . Fertil Steril. 51:1989;827-834.
18. Gabrielsen A., Lindenberg S., Petersen K. The impact of zona pellucida thickness variation of human embryos on pregnancy outcome in relation to suboptimal embryo development. Hum Reprod. 16:2001;2166-2170.
19. Albano C., Felberbaum R.E., Smitz J. Ovarial stimulation with HMG results of a prospective randomized phase III European study comparing the luteinizing hormone - releasing hormone (LH-RH)-antagonist cetrorelix and the LHRH-agonist buserelin . Hum Reprod. 15:2000;531.
20. Olivennes F., Belaisch-Allart J., Emperaire C.J. Prospective randomized, controlled study of in-vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) of a depot formula of an LH-RH agonist (triptorelin). Fertil Steril. 73:2000;314-320.
21. Roulier R, Chabert-Orsini V, Sitri MC, Barry B. Utilisation des antagonistes de la LHRH (Cetrotide® 3 mg) en pratique courante dans une population non électionnée: étude prospective, randomisée, comparative versus agonistes retard de la GnRH. Federation Française d'Etudes de la Reproduction, 5. to 7.9.2001, Palais des Congres Lyon, France 2001.
22. Ludwig M., Katalinic A., Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproduction technologies compared to the long protocol. Arch Gynecol Obstet. 265:2001;175-182.